Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis

IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA neurology 2017-12, Vol.74 (12), p.1425-1430
Hauptverfasser: O’Brien, Margaret, Burke, Tom, Heverin, Mark, Vajda, Alice, McLaughlin, Russell, Gibbons, John, Byrne, Susan, Pinto-Grau, Marta, Elamin, Marwa, Pender, Niall, Hardiman, Orla
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1430
container_issue 12
container_start_page 1425
container_title JAMA neurology
container_volume 74
creator O’Brien, Margaret
Burke, Tom
Heverin, Mark
Vajda, Alice
McLaughlin, Russell
Gibbons, John
Byrne, Susan
Pinto-Grau, Marta
Elamin, Marwa
Pender, Niall
Hardiman, Orla
description IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in AL
doi_str_mv 10.1001/jamaneurol.2017.2699
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5822189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2657325</ama_id><sourcerecordid>29049464</sourcerecordid><originalsourceid>FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</originalsourceid><addsrcrecordid>eNpVkdFKwzAUhoMobsy9gIjkBTqTNE2aG2FMp8JQcYKXIU3TNaNrR9INdumbmzK3aW5yyDn_d_7wA3CD0QgjhO-WaqVqs3FNNSII8xFhQpyBPsEsjRhO-PmxpqIHht4vUTgpQjSml6BHBKKCMtoH35Nq41vjbL2ATQFfO-ba73RpVeushg_WG-UNtDWcWufb6MEsnDFQ1TmcG93U-eHlw1SqtVvjO857KE3devhl2xKOV7umDdwyAGcqbFMVnOvKuMZbfwUuClV5M_y9B2A-ffycPEezt6eXyXgWKUp4G5E8QTnOw6eylAiFVIxSmjGmU8Y14XmWCE5xN6KyNOEZE5rEhAtSxBzjeADu99T1JluZXAdzwYVcO7tSbicbZeX_Tm1LuWi2MkkJwakIALoH6ODaO1MctRjJLhN5ykR2mcgukyC7_bv3KDokEAau9wNBfeqyhMckiX8A9QuWTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</creator><creatorcontrib>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</creatorcontrib><description>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2017.2699</identifier><identifier>PMID: 29049464</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Aged ; Alcoholism - epidemiology ; Alcoholism - genetics ; Alcoholism - psychology ; Amyotrophic Lateral Sclerosis - epidemiology ; Amyotrophic Lateral Sclerosis - genetics ; Autistic Disorder - epidemiology ; Autistic Disorder - genetics ; Autistic Disorder - psychology ; C9orf72 Protein - genetics ; Case-Control Studies ; Depressive Disorder - epidemiology ; Depressive Disorder - genetics ; Depressive Disorder - psychology ; Family - psychology ; Female ; Genetic Predisposition to Disease ; Humans ; Ireland - epidemiology ; Male ; Mental Disorders - epidemiology ; Mental Disorders - genetics ; Mental Disorders - psychology ; Middle Aged ; Online First ; Original Investigation ; Psychotic Disorders - epidemiology ; Psychotic Disorders - genetics ; Psychotic Disorders - psychology ; Risk ; Schizophrenia - epidemiology ; Schizophrenia - genetics ; Schizophrenic Psychology ; Suicide - psychology ; Suicide - statistics &amp; numerical data</subject><ispartof>JAMA neurology, 2017-12, Vol.74 (12), p.1425-1430</ispartof><rights>Copyright 2017 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2017.2699$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2017.2699$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,776,780,881,3327,27901,27902,76232,76235</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29049464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O’Brien, Margaret</creatorcontrib><creatorcontrib>Burke, Tom</creatorcontrib><creatorcontrib>Heverin, Mark</creatorcontrib><creatorcontrib>Vajda, Alice</creatorcontrib><creatorcontrib>McLaughlin, Russell</creatorcontrib><creatorcontrib>Gibbons, John</creatorcontrib><creatorcontrib>Byrne, Susan</creatorcontrib><creatorcontrib>Pinto-Grau, Marta</creatorcontrib><creatorcontrib>Elamin, Marwa</creatorcontrib><creatorcontrib>Pender, Niall</creatorcontrib><creatorcontrib>Hardiman, Orla</creatorcontrib><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><title>JAMA neurology</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</description><subject>Aged</subject><subject>Alcoholism - epidemiology</subject><subject>Alcoholism - genetics</subject><subject>Alcoholism - psychology</subject><subject>Amyotrophic Lateral Sclerosis - epidemiology</subject><subject>Amyotrophic Lateral Sclerosis - genetics</subject><subject>Autistic Disorder - epidemiology</subject><subject>Autistic Disorder - genetics</subject><subject>Autistic Disorder - psychology</subject><subject>C9orf72 Protein - genetics</subject><subject>Case-Control Studies</subject><subject>Depressive Disorder - epidemiology</subject><subject>Depressive Disorder - genetics</subject><subject>Depressive Disorder - psychology</subject><subject>Family - psychology</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Ireland - epidemiology</subject><subject>Male</subject><subject>Mental Disorders - epidemiology</subject><subject>Mental Disorders - genetics</subject><subject>Mental Disorders - psychology</subject><subject>Middle Aged</subject><subject>Online First</subject><subject>Original Investigation</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Psychotic Disorders - genetics</subject><subject>Psychotic Disorders - psychology</subject><subject>Risk</subject><subject>Schizophrenia - epidemiology</subject><subject>Schizophrenia - genetics</subject><subject>Schizophrenic Psychology</subject><subject>Suicide - psychology</subject><subject>Suicide - statistics &amp; numerical data</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkdFKwzAUhoMobsy9gIjkBTqTNE2aG2FMp8JQcYKXIU3TNaNrR9INdumbmzK3aW5yyDn_d_7wA3CD0QgjhO-WaqVqs3FNNSII8xFhQpyBPsEsjRhO-PmxpqIHht4vUTgpQjSml6BHBKKCMtoH35Nq41vjbL2ATQFfO-ba73RpVeushg_WG-UNtDWcWufb6MEsnDFQ1TmcG93U-eHlw1SqtVvjO857KE3devhl2xKOV7umDdwyAGcqbFMVnOvKuMZbfwUuClV5M_y9B2A-ffycPEezt6eXyXgWKUp4G5E8QTnOw6eylAiFVIxSmjGmU8Y14XmWCE5xN6KyNOEZE5rEhAtSxBzjeADu99T1JluZXAdzwYVcO7tSbicbZeX_Tm1LuWi2MkkJwakIALoH6ODaO1MctRjJLhN5ykR2mcgukyC7_bv3KDokEAau9wNBfeqyhMckiX8A9QuWTg</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>O’Brien, Margaret</creator><creator>Burke, Tom</creator><creator>Heverin, Mark</creator><creator>Vajda, Alice</creator><creator>McLaughlin, Russell</creator><creator>Gibbons, John</creator><creator>Byrne, Susan</creator><creator>Pinto-Grau, Marta</creator><creator>Elamin, Marwa</creator><creator>Pender, Niall</creator><creator>Hardiman, Orla</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20171201</creationdate><title>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</title><author>O’Brien, Margaret ; Burke, Tom ; Heverin, Mark ; Vajda, Alice ; McLaughlin, Russell ; Gibbons, John ; Byrne, Susan ; Pinto-Grau, Marta ; Elamin, Marwa ; Pender, Niall ; Hardiman, Orla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a427t-2d50d1d168b829a0a3084b66c867c27db597410d1dab857b69c232792f37113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Alcoholism - epidemiology</topic><topic>Alcoholism - genetics</topic><topic>Alcoholism - psychology</topic><topic>Amyotrophic Lateral Sclerosis - epidemiology</topic><topic>Amyotrophic Lateral Sclerosis - genetics</topic><topic>Autistic Disorder - epidemiology</topic><topic>Autistic Disorder - genetics</topic><topic>Autistic Disorder - psychology</topic><topic>C9orf72 Protein - genetics</topic><topic>Case-Control Studies</topic><topic>Depressive Disorder - epidemiology</topic><topic>Depressive Disorder - genetics</topic><topic>Depressive Disorder - psychology</topic><topic>Family - psychology</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Ireland - epidemiology</topic><topic>Male</topic><topic>Mental Disorders - epidemiology</topic><topic>Mental Disorders - genetics</topic><topic>Mental Disorders - psychology</topic><topic>Middle Aged</topic><topic>Online First</topic><topic>Original Investigation</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Psychotic Disorders - genetics</topic><topic>Psychotic Disorders - psychology</topic><topic>Risk</topic><topic>Schizophrenia - epidemiology</topic><topic>Schizophrenia - genetics</topic><topic>Schizophrenic Psychology</topic><topic>Suicide - psychology</topic><topic>Suicide - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O’Brien, Margaret</creatorcontrib><creatorcontrib>Burke, Tom</creatorcontrib><creatorcontrib>Heverin, Mark</creatorcontrib><creatorcontrib>Vajda, Alice</creatorcontrib><creatorcontrib>McLaughlin, Russell</creatorcontrib><creatorcontrib>Gibbons, John</creatorcontrib><creatorcontrib>Byrne, Susan</creatorcontrib><creatorcontrib>Pinto-Grau, Marta</creatorcontrib><creatorcontrib>Elamin, Marwa</creatorcontrib><creatorcontrib>Pender, Niall</creatorcontrib><creatorcontrib>Hardiman, Orla</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O’Brien, Margaret</au><au>Burke, Tom</au><au>Heverin, Mark</au><au>Vajda, Alice</au><au>McLaughlin, Russell</au><au>Gibbons, John</au><au>Byrne, Susan</au><au>Pinto-Grau, Marta</au><au>Elamin, Marwa</au><au>Pender, Niall</au><au>Hardiman, Orla</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis</atitle><jtitle>JAMA neurology</jtitle><addtitle>JAMA Neurol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>74</volume><issue>12</issue><spage>1425</spage><epage>1430</epage><pages>1425-1430</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>29049464</pmid><doi>10.1001/jamaneurol.2017.2699</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-6149
ispartof JAMA neurology, 2017-12, Vol.74 (12), p.1425-1430
issn 2168-6149
2168-6157
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5822189
source MEDLINE; American Medical Association Journals
subjects Aged
Alcoholism - epidemiology
Alcoholism - genetics
Alcoholism - psychology
Amyotrophic Lateral Sclerosis - epidemiology
Amyotrophic Lateral Sclerosis - genetics
Autistic Disorder - epidemiology
Autistic Disorder - genetics
Autistic Disorder - psychology
C9orf72 Protein - genetics
Case-Control Studies
Depressive Disorder - epidemiology
Depressive Disorder - genetics
Depressive Disorder - psychology
Family - psychology
Female
Genetic Predisposition to Disease
Humans
Ireland - epidemiology
Male
Mental Disorders - epidemiology
Mental Disorders - genetics
Mental Disorders - psychology
Middle Aged
Online First
Original Investigation
Psychotic Disorders - epidemiology
Psychotic Disorders - genetics
Psychotic Disorders - psychology
Risk
Schizophrenia - epidemiology
Schizophrenia - genetics
Schizophrenic Psychology
Suicide - psychology
Suicide - statistics & numerical data
title Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T23%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clustering%20of%20Neuropsychiatric%20Disease%20in%20First-Degree%20and%20Second-Degree%20Relatives%20of%20Patients%20With%20Amyotrophic%20Lateral%20Sclerosis&rft.jtitle=JAMA%20neurology&rft.au=O%E2%80%99Brien,%20Margaret&rft.date=2017-12-01&rft.volume=74&rft.issue=12&rft.spage=1425&rft.epage=1430&rft.pages=1425-1430&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2017.2699&rft_dat=%3Cpubmed_cross%3E29049464%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29049464&rft_ama_id=2657325&rfr_iscdi=true